Cosmegen Articles
Rx drug prices "double" US political impact
18 August 2008
Sandoz MDR Drug Shows Promise In Early Trials
13 November 1995
Showing 1-2 of 2 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
